Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-018221

SVP & Chief Operating Officer sold 220,144 shares at an average $99.27 ($21,854,265)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nicholson John SVP & Chief Operating Officer 2018-03-06 Sale −120,000 $98.29 $11,794,800 267,657 D: show line 1 in the form
Nicholson John SVP & Chief Operating Officer 2018-03-07 Sale −100,144 $100.45 $10,059,465 167,513 D: show line 2 in the form
Open-market sales · 220,144 sh · avg $99.27 · $21,854,265
Loading xslF345X03/doc4.xml…